"For more than two years, some of the world's leading researchers have compiled & analyzed extensive data which will be useful in both clinical practice & future clinical trials for kidney disease," said Dr. Andrew Levey, professor of medicine at #TUSMhttp://markets.businessinsider.com/news/stocks/accelerating-new-clinical-trials-and-treatments-for-kidney-disease-1018859675 …
0 replies
0 retweets
1 like
Loading seems to be taking a while.
Twitter may be over capacity or experiencing a momentary hiccup. Try again or visit Twitter Status for more information.